I² Statistic
The engine for Heterogeneity Discovery. The I² statistic audits the total variability in a meta-analysis, revealing exactly what percentage of the differences between studies are 'Real' rather than mere random chance.
What is it?
I² Statistic is designed to mathematically synthesize evidence across multiple independent studies to resolve clinical uncertainty.
The engine for Heterogeneity Discovery. The I² statistic audits the total variability in a meta-analysis, revealing exactly what percentage of the differences between studies are 'Real' rather than mere random chance.
Goals & Indications
- Heterogeneity Quantification: Determine if the divergence in your study cluster represents meaningful scientific differences.
- Model Selection Audit: Use the 'Percent of Inconsistency' to decide between Fixed-Effects and Random-Effects paths.
- Discovery Stability Mapping: Identify if your pooled estimate is built on a unified signal or a fragmented, messy reality.
Core Idea Diagram
Hypotheses
How it works
- Compute Cochran's Q statistic to measure overall study effect deviation.
- Determine degrees of freedom: df = k - 1 (k is number of studies).
- Calculate I² = max(0, (Q - df)/Q) * 100%.
- Heterogeneity is graded: low (<25%), moderate (50%), high (>75%).
Assumptions
Important Note
I² is a descriptive index quantifying the percentage of total variability in effect sizes attributable to true heterogeneity (between-study variance) rather than sampling error. Unlike Cochran's Q test, I² does not test a null hypothesis. Instead, it provides an interpretable measure (0-100%) indicating heterogeneity magnitude. I² = 0% means all variability is due to sampling error (homogeneous effects); I² = 100% means all variability is due to true differences between studies. I² is scale-free (unlike τ²) and relatively independent of k (unlike Q test power). Always report I² with 95% confidence interval to convey precision. Formula: I² = max(0, 100% × (Q - df) / Q) = 100% × (H² - 1) / H².
Worked Example
| Q (df) | I² Val | Grade |
|---|---|---|
| 3.2 (df=4) | 0.0% | None |
| 10.5 (df=4) | 61.9% | Moderate |
| 22.4 (df=4) | 82.1% | High |
$I^2$ Variance Decomposition Sandbox
Toggle between-study variance vs. within-study precision. Watch the proportion of total variance due to true heterogeneity ($I^2$) shift in real-time.
Hypotheses
Pragmatic null and alternative hypotheses defined in mathematical notation.
Not applicable - I² is a descriptive statistic, not a hypothesis test
Not applicable - I² quantifies heterogeneity magnitude, use Cochran's Q for hypothesis testing
I² is a descriptive index quantifying the percentage of total variability in effect sizes attributable to true heterogeneity (between-study variance) rather than sampling error. Unlike Cochran's Q test, I² does not test a null hypothesis. Instead, it provides an interpretable measure (0-100%) indicating heterogeneity magnitude. I² = 0% means all variability is due to sampling error (homogeneous effects); I² = 100% means all variability is due to true differences between studies. I² is scale-free (unlike τ²) and relatively independent of k (unlike Q test power). Always report I² with 95% confidence interval to convey precision. Formula: I² = max(0, 100% × (Q - df) / Q) = 100% × (H² - 1) / H².
Assumptions
The core mathematical criteria needed to ensure that statistical testing remains unbiased and valid.
Diagnostics
Checking residual plots and indices to examine model deviations and ensure standard error integrity.
- I² percentage with 95% confidence interval (CRITICAL - precision matters)
- Interpretation category: low (<25%), moderate (25-50%), substantial (50-75%), considerable (>75%)
- Cochran's Q statistic with degrees of freedom and p-value (hypothesis test companion)
- τ² (tau-squared) as absolute heterogeneity measure alongside I²
- Number of studies (k) to contextualize I² precision
- Forest plot showing visual heterogeneity across studies
- H² statistic (H² = Q/df) as alternative heterogeneity index
- Subgroup-specific I² if conducting subgroup meta-analysis
- I² stability across leave-one-out sensitivity analyses
- Comparison of I² before and after publication bias adjustment (trim-and-fill, PET-PEESE)
- Prediction interval width (complements I² for generalizability assessment)
- Influence diagnostics showing which studies most impact heterogeneity
- I² compared across different τ² estimators (DL, REML, PM) for robustness
- Graphical display: I² with 95% CI in APA-style figure
Applied Minds
Review concrete study examples, data layout guidelines, and copy executable syntax scripts.
Psychotherapy Meta-Analysis
Research question: What percentage of variability in psychotherapy effects for anxiety disorders is due to true heterogeneity rather than sampling error? Design: Calculate I² statistic with 95% CI from k=12 randomized controlled trials (total N=1,523 participants) examining CBT, exposure therapy, and other psychotherapies vs. control for anxiety. Outcome: Standardized mean difference (Hedges' g) in anxiety symptoms at post-treatment. This example demonstrates complete I² calculation including confidence interval estimation using the non-central chi-square method. I² is interpreted alongside Cochran's Q test, τ², and heterogeneity investigation via subgroup analysis. The example shows how I² guides model selection (fixed vs. random effects) and identifies when moderator analysis is warranted.
# I² Statistic Calculation with 95% Confidence Interval
# Demonstrating heterogeneity quantification in psychotherapy meta-analysis
library(metafor) # rma() for meta-analysis and confint() for I² CI
library(meta) # forest() plotting
library(dplyr)
library(ggplot2)
# === STEP 1: Simulate Meta-Analytic Dataset ===
# In practice: data <- read.csv("meta_analysis_data.csv")
# Required: effect sizes (Hedges' g) and variances
set.seed(2025)
k <- 12 # Number of studies
# Simulate effect sizes with substantial heterogeneity
# True effects vary: mean θ=0.75, between-study SD τ=0.30 (substantial)
true_effects <- rnorm(k, mean=0.75, sd=0.30)
# Sample sizes vary
n_treat <- sample(50:100, k, replace=TRUE)
n_control <- sample(50:100, k, replace=TRUE)
total_n <- n_treat + n_control
# Sampling standard errors
sampling_se <- sqrt((n_treat + n_control)/(n_treat * n_control) +
true_effects^2 / (2*(n_treat + n_control)))
# Observed effect sizes
observed_g <- rnorm(k, mean=true_effects, sd=sampling_se)
variance_g <- sampling_se^2
# Create dataset
meta_data <- data.frame(
study_id = paste0("Study_", 1:k),
author_year = paste0(LETTERS[1:k], " et al.(20", 12:23, ")"),
therapy_type = sample(c("CBT", "Exposure", "Other"), k, replace=TRUE),
hedges_g = observed_g,
variance = variance_g,
se = sqrt(variance_g),
n_treatment = n_treat,
n_control = n_control,
total_n = total_n
)
print("=== Meta-Analytic Dataset ===")
print(meta_data)
cat("\nTotal N =", sum(meta_data$total_n), "participants across", k, "studies\n")
# === STEP 2: Calculate Cochran's Q Statistic ===
# Q is foundation for I² calculation
# Fixed-effects weights
w_fixed <- 1 / meta_data$variance
# Fixed-effects pooled estimate
pooled_fixed <- sum(w_fixed * meta_data$hedges_g) / sum(w_fixed)
# Cochran's Q = Σw_i(y_i - ȳ)²
Q <- sum(w_fixed * (meta_data$hedges_g - pooled_fixed)^2)
df_Q <- k - 1 # Degrees of freedom
cat("\n=== Cochran's Q Statistic ===")
cat("\nQ(", df_Q, ") =", round(Q, 3))
# Q test p-value (chi-square distribution)
Q_pval <- 1 - pchisq(Q, df_Q)
cat("\np-value =", format.pval(Q_pval, digits=3))
if (Q_pval < 0.10) {
cat("\n→ Significant heterogeneity detected(p < .10)")
} else {
cat("\n→ No significant heterogeneity(p ≥ .10)")
}
# === STEP 3: Calculate I² Statistic ===
# I² = max(0, 100% × (Q - df) / Q)
# This is the percentage of total variance due to heterogeneity
I2_point <- max(0, 100 * (Q - df_Q) / Q)
cat("\n\n=== I² Statistic ===")
cat("\nI² =", round(I2_point, 2), "%")
# Interpretation category
if (I2_point < 25) {
I2_category <- "low"
I2_meaning <- "might not be important"
} else if (I2_point < 50) {
I2_category <- "moderate"
I2_meaning <- "may represent moderate heterogeneity"
} else if (I2_point < 75) {
I2_category <- "substantial"
I2_meaning <- "may represent substantial heterogeneity"
} else {
I2_category <- "considerable"
I2_meaning <- "represents considerable heterogeneity"
}
cat("\nCategory:", I2_category)
cat("\nInterpretation:", I2_meaning)
# === STEP 4: CRITICAL - Calculate 95% Confidence Interval for I² ===
# Uses non-central chi-square distribution method
# CI reflects uncertainty in I² estimate (especially important with small k)
# Function to calculate I² CI using non-central chi-square method
calculate_I2_CI <- function(Q, df, alpha=0.05) {
# Lower bound: Find non-centrality parameter λ_L such that P(χ²_df(λ_L) > Q) = alpha/2
# Upper bound: Find λ_U such that P(χ²_df(λ_U) < Q) = alpha/2
# Lower CI for I²
if (Q > df) {
# Solve for λ_L: P(χ²_df(λ_L) ≥ Q) = 1 - alpha/2
# This requires finding λ such that Q is at (1-alpha/2) quantile of χ²_df(λ)
# Approximation: Use iterative search
find_ncp_lower <- function(ncp) {
pchisq(Q, df=df, ncp=ncp, lower.tail=FALSE) - (1 - alpha/2)
}
if (find_ncp_lower(0) < 0) {
# Q is extreme; use root finding
lambda_L <- tryCatch({
uniroot(find_ncp_lower, c(0, Q))$root
}, error = function(e) 0)
} else {
lambda_L <- 0
}
I2_lower <- max(0, 100 * lambda_L / Q)
} else {
I2_lower <- 0
}
# Upper CI for I²
find_ncp_upper <- function(ncp) {
pchisq(Q, df=df, ncp=ncp, lower.tail=TRUE) - alpha/2
}
lambda_U <- tryCatch({
# Search up to 4×Q for upper bound
uniroot(find_ncp_upper, c(0, max(Q*4, 100)))$root
}, error = function(e) Q) # If fails, use Q as conservative upper
I2_upper <- min(100, 100 * lambda_U / Q)
return(c(lower = I2_lower, upper = I2_upper))
}
I2_CI <- calculate_I2_CI(Q, df_Q)
cat("\n\n=== I² with 95% Confidence Interval ===")
cat("\nI² =", round(I2_point, 1), "%, 95% CI [",
round(I2_CI[1], 1), "%, ", round(I2_CI[2], 1), "%]")
CI_width <- I2_CI[2] - I2_CI[1]
cat("\nCI width =", round(CI_width, 1), "percentage points")
if (CI_width > 40) {
cat("\n→ Wide CI indicates imprecise I² estimate(common with k < 10)")
} else if (CI_width > 25) {
cat("\n→ Moderate CI width; I² estimate has some uncertainty")
} else {
cat("\n→ Narrow CI indicates precise I² estimate")
}
cat("\n\nInterpretation:", I2_category, "heterogeneity(", I2_meaning, ")")
cat("\nTrue I² likely falls between", round(I2_CI[1], 1), "% and",
round(I2_CI[2], 1), "%")
# === STEP 5: Run Random-Effects Meta-Analysis for Complete Output ===
# metafor provides I² automatically with other heterogeneity statistics
re_model <- rma(yi = hedges_g, vi = variance, data = meta_data,
method = "REML", slab = author_year)
cat("\n\n=== Random-Effects Meta-Analysis Results ===")
print(re_model)
# Extract statistics
pooled_g <- as.numeric(re_model$beta)
ci_lower <- re_model$ci.lb
ci_upper <- re_model$ci.ub
tau2 <- re_model$tau2
tau <- sqrt(tau2)
I2_metafor <- re_model$I2
H2 <- re_model$H2
cat("\n=== Comprehensive Heterogeneity Statistics ===")
cat("\nI² =", round(I2_metafor, 1), "% (from metafor)")
cat("\nτ² (tau-squared) =", round(tau2, 4))
cat("\nτ (tau, between-study SD) =", round(tau, 3))
cat("\nH² =", round(H2, 2))
cat("\nQ(", df_Q, ") =", round(Q, 2), ", p =", format.pval(Q_pval, digits=3))
# Verify I² formula: I² = (Q - df) / Q × 100%
I2_manual <- max(0, 100 * (Q - df_Q) / Q)
cat("\n\nVerification: I² = (Q - df) / Q × 100%")
cat("\n = (", round(Q, 2), " - ", df_Q, ") / ", round(Q, 2), " × 100%")
cat("\n =", round(I2_manual, 2), "%")
# Alternative formula: I² = (H² - 1) / H² × 100%
I2_from_H2 <- 100 * (H2 - 1) / H2
cat("\n\nAlternative formula: I² = (H² - 1) / H² × 100%")
cat("\n = (", round(H2, 2), " - 1) / ", round(H2, 2), " × 100%")
cat("\n =", round(I2_from_H2, 2), "%")
# === STEP 6: Get 95% CI for I² using metafor's confint() ===
# More rigorous than manual calculation
I2_confint <- confint(re_model, digits=2)
cat("\n\n=== metafor confint() for I² ===")
cat("\nI² =", round(I2_metafor, 1), "%")
cat("\n95% CI: [", round(I2_confint$random["I^2(%)", "ci.lb"], 1), "%, ",
round(I2_confint$random["I^2(%)", "ci.ub"], 1), "%]")
# === STEP 7: Visual Interpretation - Forest Plot ===
par(mar=c(5,4,4,2))
forest(re_model,
xlab = "Hedges' g(Psychotherapy - Control)",
header = c("Study", "g [95% CI]"),
cex = 0.8,
col = "blue",
border = "blue")
title(main = paste0("Forest Plot: Psychotherapy for Anxiety(k=", k, " studies)\n",
"I² = ", round(I2_metafor, 1), "% (", I2_category,
" heterogeneity), 95% CI [",
round(I2_confint$random["I^2(%)", "ci.lb"], 1), "%, ",
round(I2_confint$random["I^2(%)", "ci.ub"], 1), "%]"),
cex.main = 0.9, line = 0.5)
# Add visual heterogeneity annotation
mtext(paste0("Q(", df_Q, ") = ", round(Q, 2), ", p ",
ifelse(Q_pval < 0.001, "< .001", paste0("= ", round(Q_pval, 3)))),
side = 3, line = -1.5, cex = 0.8)
# === STEP 8: I² by Subgroup (Investigating Heterogeneity Source) ===
# When I² > 50%, investigate moderators
if (I2_metafor > 50) {
cat("\n\n=== I² > 50%: Investigating Heterogeneity via Subgroup Analysis ===")
# Subgroup analysis by therapy type
subgroup_model <- rma(yi = hedges_g, vi = variance, data = meta_data,
mods = ~ therapy_type - 1, method = "REML")
cat("\nSubgroup Analysis by Therapy Type:")
print(subgroup_model)
# Calculate I² within each subgroup
for (therapy in unique(meta_data$therapy_type)) {
subdata <- meta_data[meta_data$therapy_type == therapy, ]
if (nrow(subdata) >= 3) {
sub_model <- rma(yi = hedges_g, vi = variance, data = subdata, method = "REML")
cat("\n", therapy, ":", nrow(subdata), "studies")
cat("\n I² =", round(sub_model$I2, 1), "%")
cat("\n Pooled g =", round(as.numeric(sub_model$beta), 2),
", 95% CI [", round(sub_model$ci.lb, 2), ",",
round(sub_model$ci.ub, 2), "]\n")
}
}
# Test between-group heterogeneity
cat("\nBetween-group heterogeneity test:")
cat("\nQ_between =", round(subgroup_model$QM, 2))
cat("\np-value =", format.pval(subgroup_model$QMp, digits=3))
if (subgroup_model$QMp < 0.05) {
cat("\n→ Therapy type significantly moderates effect size")
cat("\n(explains some heterogeneity)")
} else {
cat("\n→ No significant moderation by therapy type")
}
}
# === STEP 9: I² Interpretation Guide ===
cat("\n\n=== I² INTERPRETATION GUIDE ===")
cat("\n\nObserved I² =", round(I2_metafor, 1), "%, 95% CI [",
round(I2_confint$random["I^2(%)", "ci.lb"], 1), "%, ",
round(I2_confint$random["I^2(%)", "ci.ub"], 1), "%]")
cat("\n\nMeaning:")
cat("\n- Approximately", round(I2_metafor, 0),
"% of total variability in effect sizes is due to")
cat("\n true heterogeneity(between-study differences), not sampling error")
cat("\n-", round(100 - I2_metafor, 0),
"% of variability is attributable to sampling error(within-study variance)")
cat("\n\nClinical Implications:")
if (I2_metafor < 25) {
cat("\n- Effects are relatively homogeneous across studies")
cat("\n- Fixed-effect and random-effects models yield similar results")
cat("\n- Pooled effect likely generalizes consistently")
} else if (I2_metafor < 50) {
cat("\n- Moderate heterogeneity suggests some true variation in effects")
cat("\n- Random-effects model preferred for pooling")
cat("\n- Consider exploratory moderator analysis")
} else if (I2_metafor < 75) {
cat("\n- Substantial heterogeneity indicates considerable true variation")
cat("\n- INVESTIGATE sources via subgroup analysis or meta-regression")
cat("\n- Report prediction interval prominently(not just CI)")
cat("\n- Pooled estimate may mask important subgroup differences")
} else {
cat("\n- Considerable heterogeneity suggests extreme variation")
cat("\n- Question whether pooling is appropriate(may be comparing apples to oranges)")
cat("\n- Focus on understanding WHY effects vary, not just pooled estimate")
cat("\n- Narrative synthesis may be more informative than single pooled effect")
}
cat("\n\nStatistical Decisions:")
cat("\n- Model choice: Random-effects model STRONGLY preferred")
cat("\n(I² >", ifelse(I2_metafor > 25, "25% indicates meaningful heterogeneity)", "0%)"))
cat("\n- Moderator analysis:",
ifelse(I2_metafor > 50, "WARRANTED(I² > 50%)",
"Consider if theory-driven(I² < 50%)"))
cat("\n- Prediction interval: ESSENTIAL for interpreting generalizability")
# === STEP 10: Comparison with τ² ===
cat("\n\n=== I² vs. τ² (Complementary Heterogeneity Measures) ===")
cat("\n\nI² (relative measure):")
cat("\n I² =", round(I2_metafor, 1), "% of total variance due to heterogeneity")
cat("\n → Scale-free; comparable across meta-analyses")
cat("\n → Interpreted via guidelines: <25% low, 25-50% moderate, etc.")
cat("\n\nτ² (absolute measure):")
cat("\n τ² =", round(tau2, 4), "(between-study variance in g² units)")
cat("\n τ =", round(tau, 3), "(between-study SD in g units)")
cat("\n → Metric-dependent; magnitude depends on effect size scale")
cat("\n → Interpret relative to pooled effect: g =", round(pooled_g, 2))
cat("\n Effects vary approximately", round(pooled_g - tau, 2), "to",
round(pooled_g + tau, 2), "(θ ± τ)")
cat("\n\nRelationship:")
cat("\n I² increases with τ² BUT also depends on study precision")
cat("\n - Same τ² yields higher I² when studies are large(precise)")
cat("\n - Same τ² yields lower I² when studies are small(imprecise)")
cat("\n → Report BOTH: I² for interpretation category, τ² for absolute magnitude")
# === STEP 11: APA-Style Reporting ===
cat("\n\n=== APA-STYLE REPORT ===")
report <- paste0(
"A random-effects meta-analysis of ", k, " RCTs(N = ", sum(meta_data$total_n),
" participants)\nexamined psychotherapy interventions vs. control for anxiety disorders. ",
"The pooled effect\nwas Hedges' g = ", round(pooled_g, 2), ", 95% CI [",
round(ci_lower, 2), ", ", round(ci_upper, 2), "],\n",
"indicating a ", ifelse(abs(pooled_g) >= 0.8, "large",
ifelse(abs(pooled_g) >= 0.5, "medium-to-large", "medium")),
" effect favoring psychotherapy.\n\n",
"Heterogeneity was ", I2_category, " (I² = ", round(I2_metafor, 1),
"%, 95% CI [", round(I2_confint$random["I^2(%)", "ci.lb"], 1), "%, ",
round(I2_confint$random["I^2(%)", "ci.ub"], 1), "%];\n",
"τ² = ", round(tau2, 3), ", τ = ", round(tau, 2), "; ",
"Q(", df_Q, ") = ", round(Q, 2),
ifelse(Q_pval < 0.001, ", p < .001", paste0(", p = ", round(Q_pval, 3))), ").\n\n",
"The I² statistic indicates that approximately ", round(I2_metafor, 0),
"% of the total variability\nin observed effect sizes is attributable to true heterogeneity(between-study differences)\n",
"rather than sampling error. "
)
if (I2_metafor > 50) {
report <- paste0(report, "Given the substantial heterogeneity, we conducted\n",
"subgroup analysis by therapy type to investigate potential moderators. ")
if (exists("subgroup_model") && subgroup_model$QMp < 0.05) {
report <- paste0(report, "Therapy type significantly\nmoderated effect sizes ",
"(Q_between = ", round(subgroup_model$QM, 2), ", p ",
ifelse(subgroup_model$QMp < 0.001, "< .001",
paste0("= ", round(subgroup_model$QMp, 3))),
"),\nexplaining a portion of the observed heterogeneity. ")
}
}
report <- paste0(report, "\n\nConclusion: Psychotherapy produces ",
ifelse(abs(pooled_g) >= 0.8, "large", "medium-to-large"),
" benefits for anxiety disorders on average,\nbut the ", I2_category,
" heterogeneity(I² = ", round(I2_metafor, 1), "%) indicates that effect\n",
"magnitude varies considerably across studies. ")
if (I2_metafor > 50) {
report <- paste0(report,
"The wide prediction interval and\nsubstantial I² suggest that treatment effects are context-dependent, warranting\n",
"careful consideration of patient characteristics and intervention specifics when\n",
"applying these findings to clinical practice. Future research should focus on\n",
"identifying moderators to predict which patients benefit most from which therapies.")
} else {
report <- paste0(report,
"The relatively\nconsistent effects across studies support broad applicability of psychotherapy\n",
"for anxiety, though individual patient factors should always be considered.")
}
cat(report)
# === STEP 12: Visual Summary of I² with CI ===
par(mar=c(5,5,4,2))
barplot(I2_metafor, ylim=c(0, 100),
col="steelblue", border="darkblue", width=0.5,
xlab="", ylab="I² (%)", cex.lab=1.2,
main=paste0("I² Statistic with 95% Confidence Interval\n",
"Psychotherapy for Anxiety Meta-Analysis"),
cex.main=1.1)
# Add CI error bars
arrows(x0=0.5, y0=I2_confint$random["I^2(%)", "ci.lb"],
x1=0.5, y1=I2_confint$random["I^2(%)", "ci.ub"],
angle=90, code=3, length=0.15, lwd=3, col="darkred")
# Add interpretation zones
abline(h=25, lty=2, col="gray50", lwd=1.5)
abline(h=50, lty=2, col="gray50", lwd=1.5)
abline(h=75, lty=2, col="gray50", lwd=1.5)
text(0.5, 12.5, "Low", cex=0.9, col="gray30")
text(0.5, 37.5, "Moderate", cex=0.9, col="gray30")
text(0.5, 62.5, "Substantial", cex=0.9, col="gray30")
text(0.5, 87.5, "Considerable", cex=0.9, col="gray30")
# Add I² value
text(0.5, I2_metafor + 8,
paste0("I² = ", round(I2_metafor, 1), "%\n",
"95% CI [", round(I2_confint$random["I^2(%)", "ci.lb"], 1), "%, ",
round(I2_confint$random["I^2(%)", "ci.ub"], 1), "%]"),
cex=1.1, font=2, col="darkblue")I² = 58.3%, 95% CI [28.6%, 76.2%], indicating substantial heterogeneity. Approximately 58% of total variability in psychotherapy effects is due to true between-study differences rather than sampling error. Cochran's Q(11) = 26.4, p = .006 confirms heterogeneity exists. τ² = 0.084 (τ = 0.29) shows effects vary with SD of 0.29 around pooled g = 0.73. Given I² > 50%, moderator analysis is warranted. Subgroup analysis by therapy type partially explains heterogeneity. Random-effects model strongly preferred. Prediction interval critical for generalizability assessment. Conclusion: Substantial heterogeneity indicates therapy effects are context-dependent; investigate sources to identify optimal treatment matching for anxiety patients.
Alternatives
Structured fallback pathways for choosing alternative tests when normality or slopes requirements fail.
- Tau-Squared Audit — Prioritize the 'Absolute Variance' over the relative percentage if study Ns are small.
- H-Index — Utilize the H-statistic to represent heterogeneity without the 0-100% floor bias.
- Floor Neutralization — I² is mathematically set to 0% if Q < df—this indicates a total lack of detectable mess.
- Bootstrap I² — Generate 95% Confidence Intervals for the inconsistency index to verify its stability.
Post-hoc
Group mean comparisons and correction controls (e.g. Tukey HSD, Bonferroni) to protect against Family-Wise Error Rates.
Post-hoc pairwise tests defined for this model.
No specific guidelines provided.
Effect Size
Understanding effect sizes (e.g., Cohen's d, Partial Eta-Squared) and clinical impact benchmarks.
Percentage (0-100%) of total variability due to heterogeneity. 0% = all variability is sampling error (homogeneous); 100% = all variability is true differences. Guidelines: <25% low, 25-50% moderate, 50-75% substantial, >75% considerable.
CRITICAL: Conveys precision of I² estimate. Wide CI (>40 percentage points) indicates high uncertainty, common with k < 10. Narrow CI indicates reliable heterogeneity quantification. Never interpret I² without CI.
Low (<25%): Minimal heterogeneity, effects consistent. Moderate (25-50%): Some variation, explore if theory-driven. Substantial (50-75%): Considerable variation, INVESTIGATE sources. Considerable (>75%): Extreme variation, question pooling appropriateness.
High I² limits generalizability; effects vary by context. Combine with prediction interval: narrow PI + moderate I² = consistent direction, variable magnitude; wide PI + high I² = some contexts show null/opposite effects.
0.2
0.5
0.8
Sample Size
Guidelines for minimum sample requirements and power analysis parameters.
The 'Stability Buffer': A minimum of 5 studies (k >= 5) is essential. The I² point estimate is notoriously unstable in small study pools, often jumping from 0% to 80% with the addition of a single trial.
| Effect Size | Parameters | Required n |
|---|---|---|
| Small Effect | Uncertain I² (Low k) | k ≈ 5 |
| Medium Effect | Stable I² (Med k) | k ≈ 15 |
| Large Effect | Precise I² (High k) | k ≈ 30 |
The 'Negative Bias' Paradox: I² can mathematically underestimate heterogeneity if the N per study is small. Audit τ² (Absolute variance) alongside I² (Relative percentage) to ensure you are seeing the full picture of the data's chaos.
Reporting
How to compile statistical results into publication prose matching APA and journal style guides.
Heterogeneity was low/moderate/substantial/considerable (I² = XX.X%, 95% CI XX.X%, XX.X%; τ² = X.XXX, τ = X.XX; Q(df) = XX.XX, p </.001/=.XXX). The I² statistic indicates that approximately XX% of the total variability in observed effect sizes is attributable to true heterogeneity (between-study differences) rather than sampling error. If I² > 50%: Given the substantial heterogeneity, we conducted subgroup/meta-regression analysis to investigate sources of variability. Interpretation: The [low/moderate/substantial/considerable heterogeneity suggests effects are consistent/variable across studies, supporting/limiting generalizability to diverse populations.]
- I² percentage (point estimate)
- 95% Confidence Interval for I² (CRITICAL - precision)critical
- Interpretation category (low/moderate/substantial/considerable)
- Cochran's Q statistic with df and p-value
- τ² (tau-squared) and τ (tau) as absolute heterogeneity measures
- Number of studies (k) to contextualize precision
- Clinical interpretation of heterogeneity impact on generalizability
Manuscript Lab
Copy standard summary tables and forensic reporting grids to outline analysis details.
| Metric | Value | 95% CI | Interpretation |
|---|---|---|---|
| I² Statistic | 45.2% | [12.4%, 68.5%] | Moderate Heterogeneity |
| Tau² (τ²) | 0.082 | [0.04, 0.15] | Variance of True Effects |
| H Statistic | 1.35 | [1.05, 1.78] | Study Dispersion |
The 'Real Difference' Meter. Tells you what percentage of the observed variation between study results is due to real differences in the studies, not just random sampling error.
The True Dispersion. The estimated variance of the distribution of true effect sizes across the study population.
Command Center
Syntax libraries and function parameters for executing calculations in stats packages.
# 1. Extract I2 from Meta object
print(meta_model$I2)
# 2. Extract with full CIs
metafor::confint(metafor_model)I² is independent of the number of studies (k), making it superior to Cochran's Q for comparing different meta-analyses. However, always report τ² alongside I² to show the absolute spread.
# Visualize Prediction Interval showing the true study spread
metafor::forest(model, addpred = TRUE)Common Mistakes
Analytical caveats and corrections to maintain modeling integrity.
References
Scholarly lineage and citation keys grounding the statistical framework.